microdosing semaglutides People are 'microdosing' weight-loss drugs. A GP explains what to watch out for microdosing semaglutide I Microdosed at

FDA-approved GLP-1 receptor agonists include: - Semaglutide (Rybelsus, Ozempic, Wegovy) - Exenatide (Bydureon BCise, Byetta) - Lixisenatide (Adlyxin) - Lixisenatide/insulin glargine (Soliqua) - Liraglutide (Saxenda, Victoza) - Liraglutide/insulin degludec (Xultophy) - Dulaglutide (Trulicity) - Tirzepatide (Mounjaro) For example, Ozempic (semaglutide) is approved for type 2 diabetes, while Wegovy (also semaglutide) is approved for obesity and overweight conditions with related health concerns

Immunohistochemical staining and western blot assays revealed increased microglial cells and activated astrocytes in the dentate gyrus of the hippocampus in rats with neuropathic pain, along with elevated expression of TNF-, IL-1, and IL-6 [43, 44]

Hatfield, J.L

Convenient dosing Once-weekly injections for some GLP-1s mean fewer doses and easier routines